REQUEST A DEMO
Total
USD $0.00
Search more companies

Rpbio Inc. (South Korea)

Main Activities: Medicinal and Botanical Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Rpbio Inc. Profile Updated: April 11, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Rpbio Inc. is a company based in South Korea, with its head office in Seoul. It operates in the Medicinal and Botanical Manufacturing sector. The enterprise was incorporated on August 05, 2016. 493 (2024) employees currently work for Rpbio Inc.. The latest financial highlights indicate a net sales revenue increase of 2.38% in Q2C2025. There was a total growth of 1.69% in Rpbio Inc.’s total assets over the same period. The net profit margin of Rpbio Inc. decreased by 3.8% in 2025.

Headquarters
634, Samseong-Ro, Gangnam-Gu
Seoul; Seoul;

Contact Details: Purchase the Rpbio Inc. report to view the information.

Website: http://rpskorea.com

Basic Information
Total Employees:
Purchase the Rpbio Inc. report to view the information.
Outstanding Shares:
Purchase the Rpbio Inc. report to view the information.
Registered Capital:
Purchase the Rpbio Inc. report to view the information.
Financial Auditors:
Purchase the Rpbio Inc. report to view the information.
Incorporation Date:
August 05, 2016
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Executive Director
Company Performance
Financial values in the chart are available after Rpbio Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
2.38%
Total Operating Revenue
2.41%
Operating Profit
-38.47%
EBITDA
-20.53%
Net Profit/Loss for the Period
-41.35%
Total Assets
1.69%
Total Equity
47.96%
Operating Profit Margin
-3.95%
Net Profit Margin
-3.8%
Return on Equity (ROE)
-5.14%
Debt / Equity
-27.75%
Quick Ratio
0.31%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?